Prelude Capital Management, LLC Artivion, Inc. Transaction History

Prelude Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$27.55 - $32.39 $7,906 - $9,295	-287 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$25.85 - $30.47 $7,418 - $8,744	287 New	287 $8,000
Q4 2018 Feb 14, 2019	SELL	$25.76 - $34.03 $10,741 - $14,190	-417 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$28.6 - $35.75 $9,037 - $11,297	316 Added 312.87%	417 $15,000
Q2 2018 Aug 14, 2018	BUY	$19.4 - $29.35 $1,959 - $2,964	101 New	101 $3,000
Q4 2017 Feb 14, 2018	SELL	$18.65 - $23.85 $177,342 - $226,789	-9,509 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$18.85 - $23.05 $179,244 - $219,182	9,509	9,509 $216,000

166

35.4M

21K

6.8K

Ticker AORT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,316,100
Market Cap $1.01B
Description
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.